MEN1 and gastrin-producing neuroendocrine tumor: This discrepancy likely reflects our inclusion of sporadic gastrinomas (77.5% well-differentiated), whereas Gibril et al.’s cohort predominantly studied MEN1-related tumors known for earlier onset.